Antituberculosis Drugs (Rifampicin and Isoniazid) Induce Liver Injury by Regulating NLRP3 Inflammasomes

Acetaminophen-induced Liver Injury Alters Expression and Activities of Cytochrome P450 Enzymes in an Age-dependent Manner in Mouse Liver

(2020) Yifan Bao et al.   DRUG METABOLISM AND DISPOSITION

The selective NLRP3 inflammasome inhibitor MCC950 alleviates cholestatic liver injury and fibrosis in mice

(2019) Junwen Qu et al.   INTERNATIONAL IMMUNOPHARMACOLOGY

Capacity of Abbott RealTime MTB RIF/INH to detect rifampicin- and isoniazid-resistant tuberculosis

(2019) S. Hofmann-Thiel et al.   INTERNATIONAL JOURNAL OF TUBERCULOSIS AND LUNG DISEASE

The role of regular liver function monitoring in anti-tuberculosis drug-induced liver injury

(2019) Tien-En Chang et al.   Journal of the Chinese Medical Association

Heterodimeric Rifampicin–Tobramycin conjugates break intrinsic resistance of Pseudomonas aeruginosa to doxycycline and chloramphenicol in vitro and in a Galleria mellonella in vivo model

(2019) Temilolu Idowu et al.   EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY

The NLRP3 Inflammasome: An Overview of Mechanisms of Activation and Regulation

(2019) Nathan Kelley et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Propofol directly induces caspase-1-dependent macrophage pyroptosis through the NLRP3-ASC inflammasome

(2019) Lingbin Sun et al.   Cell Death & Disease

NLRP3 Inflammasome and the IL-1 Pathway in Atherosclerosis

(2018) Alena Grebe et al.   CIRCULATION RESEARCH

NLRP3 inflammasome inhibition ameliorates tubulointerstitial injury in the remnant kidney model

(2018) Orestes Foresto-Neto et al.   LABORATORY INVESTIGATION

Antituberculous drugs modulate bacterial phagolysosome avoidance and autophagy in Mycobacterium tuberculosis -infected macrophages

(2018) Charlotte Genestet et al.   TUBERCULOSIS

High expression of B7-H3 and CD163 in cancer tissues indicates malignant clinicopathological status and poor prognosis of patients with urothelial cell carcinoma of the bladder

(2018) Zhili Xu et al.   Oncology Letters

Mutations inside rifampicin-resistance determining region of rpoB gene associated with rifampicin-resistance in Mycobacterium tuberculosis

(2018) Myo T. Zaw et al.   Journal of Infection and Public Health

NLRP3 Inflammasome and IL-33: Novel Players in Sterile Liver Inflammation

(2018) Katrin Neumann et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

The role of mitochondria in NLRP3 inflammasome activation

(2018) Qiuyun Liu et al.   MOLECULAR IMMUNOLOGY

Role of NLRP3 Inflammasomes in Atherosclerosis

(2017) Tadayoshi Karasawa et al.   Journal of Atherosclerosis and Thrombosis

Drug resistance mechanisms and novel drug targets for tuberculosis therapy

(2017) Md Mahmudul Islam et al.   Journal of Genetics and Genomics

NLRP3 inflammasome blockade reduces liver inflammation and fibrosis in experimental NASH in mice

(2017) Auvro R. Mridha et al.   JOURNAL OF HEPATOLOGY

What We Know About Tuberculosis Transmission: An Overview

(2017) Gavin Churchyard et al.   JOURNAL OF INFECTIOUS DISEASES

Serious Adverse Reactions From Anti-tuberculosis Drugs Among 599 Children Hospitalized for Tuberculosis

(2017) Yiyuan Li et al.   PEDIATRIC INFECTIOUS DISEASE JOURNAL

Involvement of protoporphyrin IX accumulation in the pathogenesis of isoniazid/rifampicin-induced liver injury: the prevention of curcumin

(2017) Leiyan He et al.   XENOBIOTICA

Maternal and perinatal mortality and morbidity associated with tuberculosis during pregnancy and the postpartum period: a systematic review and meta-analysis

(2016) S Sobhy et al.   BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY

Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis

(2016) Ameeruddin Nusrath Unissa et al.   INFECTION GENETICS AND EVOLUTION

Inhibition of NLRP3 Inflammasome Prevents LPS-Induced Inflammatory Hyperalgesia in Mice: Contribution of NF-κB, Caspase-1/11, ASC, NOX, and NOS Isoforms

(2016) Abdurrahman Dolunay et al.   INFLAMMATION

Tuberculosis

(2016) Keertan Dheda et al.   LANCET

tagSNP rs1495741 as a useful molecular marker to predict antituberculosis drug-induced hepatotoxicity

(2016) Julián G. Chamorro et al.   Pharmacogenetics and Genomics

Naringenin protects against isoniazid- and rifampicin-induced apoptosis in hepatic injury

(2016) Chao Wang et al.   WORLD JOURNAL OF GASTROENTEROLOGY

The effects of Insulin Pre-Administration in Mice Exposed to Ethanol: Alleviating Hepatic Oxidative Injury through Anti-Oxidative, Anti-Apoptotic Activities and Deteriorating Hepatic Steatosis through SRBEP-1c Activation

(2015) Jiangzheng Liu et al.   International Journal of Biological Sciences

Isoniazid-induced polyneuropathy in a tuberculosis patient - implication for individual risk stratification with genotyping?

(2015) Mark Stettner et al.   Brain and Behavior

In vitro toxic action potential of anti tuberculosis drugs and their combinations

(2013) Riffat Fatima et al.   ENVIRONMENTAL TOXICOLOGY AND PHARMACOLOGY